Article
Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primates
2022-03-01
Abstract excerpt
<h4>ABSTRACT</h4> SARS-CoV-2 has infected more than 400 million people around the globe and caused millions of deaths. Since its identification in November 2021, Omicron, a highly transmissible variant, has become the dominant variant in most countries. Omicron’s highly mutated spike protein, the main target of vaccine development, significantly compromises the immune protection from current vaccination. We devel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d74c75a-bc01-5353-9df6-16349b86e1d6
- DOI
- 10.1101/2022.03.01.481391
